Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the hematological, cytogenetic and molecular response to continuous-use of Imatinib in children with CML Ph+.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01221376
Study type Interventional
Source Hospital Santa Marcelina
Contact
Status Active, not recruiting
Phase Phase 2
Start date February 2011
Completion date December 2013